Visian Toric Implantable Collamer Lens for Correction of Compound Myopic Astigmatism

Elíes, Daniel; Alonso, Tirso; Puig, Javier Salas; Gris, Óscar; Güell, José L.; Coret, Andreu

doi:10.3928/1081597x-20100218-02

Cited by 15 publications

(9 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…It has been reported that the toric pIOL has high efficacy, safety, and predictability for the correction of myopic astigmatism. [1][2][3] Moreover, recent studies 4,5 report that the toric pIOL has better efficacy and predictability than photorefractive keratectomy or laser in situ keratomileusis (LASIK) in eyes with high myopic astigmatism. However, unlike iris-fixated pIOLs, the toric pIOL does not hold the iris tissue; thus, there is a risk for loose fixation of the pIOL.…”

Section: Resultsmentioning

confidence: 97%

Factors affecting rotation of a posterior chamber collagen copolymer toric phakic intraocular lens

Mōri

Yokoyama

Kojima

et al. 2012

Journal of Cataract and Refractive Surgery

View full text Add to dashboard Cite

show abstract

Section: Resultsmentioning

confidence: 97%

Factors affecting rotation of a posterior chamber collagen copolymer toric phakic intraocular lens

Mōri

Yokoyama

Kojima

et al. 2012

Journal of Cataract and Refractive Surgery

View full text Add to dashboard Cite

show abstract

“…Another toric pIOL is the Visian Implantable Collamer Lens (Staar Surgical), which can be implanted behind the iris in the ciliary sulcus. Elies et al 30 report that 52.5% of eyes with this pIOL were within G1.0 D of the intended correction 6 months postoperatively.…”

Section: Discussionmentioning

confidence: 96%

Correction of myopic astigmatism with a foldable iris-claw toric phakic intraocular lens: Short-term follow-up

Ruckhofer¹,

Seyeddain²,

Dexl³

et al. 2012

Journal of Cataract and Refractive Surgery

View full text Add to dashboard Cite

show abstract

“…However, the validity of use of ICL in lower degrees of myopia and myopic astigmatism as a primary treatment modality has already been verified 4. For the correction of myopic astigmatism in particular, both LASIK and toric implantable collamer lens (T-ICL) have been shown to be safe and effective in various studies 5–8. It was found that LASIK was effective for correction of astigmatism up to 4.5 D,6 while T-ICL provided safe and stable results with astigmatism up to 7 D in long-term studies 8…”

Section: Introductionmentioning

confidence: 99%

Matched population comparison of visual outcomes and patient satisfaction between 3 modalities for the correction of low to moderate myopic astigmatism

Ganesh¹,

Brar²,

Pawar³

2017

OPTH

View full text Add to dashboard Cite

PurposeTo compare toric implantable collamer lens (T-ICL), femto-LASIK, and ReLEx SMILE for the treatment of low to moderate myopic astigmatism in terms of long-term visual and refractive outcomes and predictability of astigmatic correction.Materials and methodsThe study included 30 eyes from 30 patients between the age groups of 21 and 40 years, undergoing bilateral surgery with any of the three procedures – T-ICL, femto-LASIK, or ReLEx SMILE – for correction of myopic astigmatism within the range of −3 to −8 D spherical equivalent (SE), with a minimum astigmatism of −0.75 D. Patients were followed up at day 1, 1 month, 6 months, and 1 year.ResultsAt 1 year, the mean cylinder reduced to −0.21±0.28, −0.17±0.36, and −0.22±0.28 D in the T-ICL, femto-LASIK, and ReLEx SMILE group, respectively. The predictability of astigmatism correction was comparable, with no statistically significant difference between the 3 groups (P>0.05). A total of 97% of eyes in ReLEx SMILE achieved a uncorrected distance visual acuity of 20/20 or better, compared to T-ICL (93%) and FS-LASIK (90%). However, gain in lines of corrected distant visual acuity (CDVA) was maximum in T-ICL group (60%). Four eyes in the femto-LASIK group had loss of CDVA by one line. Three eyes required exchange due to high vault and rotation of the T-ICL, which did not affect the final outcome.ConclusionAll 3 modalities were effective for myopic astigmatism at the end of 1 year. Quality of vision and patient satisfaction with T-ICL and ReLEx SMILE were similar and better than FS-LASIK. However, slight chances of postoperative rotation and exchange exist with T-ICL, which warrant thorough preoperative planning.

show abstract

Visian Toric Implantable Collamer Lens for Correction of Compound Myopic Astigmatism

Abstract: Implantation of the STAAR TICL was an effective, predictable, and safe method for correction of high myopia and myopic astigmatism as shown in this retrospective observational series.

Cited by 15 publications

References 28 publications

Factors affecting rotation of a posterior chamber collagen copolymer toric phakic intraocular lens

Factors affecting rotation of a posterior chamber collagen copolymer toric phakic intraocular lens

Correction of myopic astigmatism with a foldable iris-claw toric phakic intraocular lens: Short-term follow-up

Matched population comparison of visual outcomes and patient satisfaction between 3 modalities for the correction of low to moderate myopic astigmatism

Contact Info

Product

Resources

About